GlassScriptPhysician profile
William J Smolinski
NPI 1861402117
$13,884.48
in general payments reported to CMS, 2019-2025
31 companies · $2,261 in 2025
The $2,261 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,020 · 2020: $1,568 · 2021: $1,655 · 2022: $2,115 · 2023: $2,150 · 2024: $2,116 · 2025: $2,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,527.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,180.83 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, General - Therapies |
| Pfizer INC. | $2,032.65 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,472.87 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $1,286.65 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $913.28 | 2019-2025 | Brilinta, Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $862.03 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $695.93 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $590.48 | 2021-2025 | Verquvo |
| Amarin Pharma, INC. | $588.41 | 2019-2023 | |
| Amgen INC. | $573.92 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $563.73 | 2020-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $413.27 | 2019-2022 | |
| Novo Nordisk INC | $306.73 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $271.15 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Sanofi-Aventis U.S. LLC | $249.67 | 2019-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $170.48 | 2022-2025 | |
| Scpharmaceuticals INC. | $112.81 | 2025 | |
| Daiichi Sankyo INC. | $72.25 | 2023-2024 | Injectafer |
| Alnylam Pharmaceuticals INC. | $69.35 | 2025 | Onpattro |
| Lilly USA, LLC | $67.16 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Lexicon Pharmaceuticals, INC. | $66.96 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.25 | 2019-2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $51.17 | 2019 | |
| Lundbeck LLC | $43.60 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $40.98 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $29.78 | 2022 | |
| Vifor Pharma, INC. | $24.64 | 2019 | |
| Baxter Healthcare | $20.34 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $20.07 | 2020 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Abbvie INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Smolinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.